Cited by 106Asthma and respiratory diseasesOccupational exposure and asthmaIL-33, ST2, and ILC Pathways

Severe asthma in children

Bush, Andrew, Fleming, Louise, Saglani, Sejal·2017·Respirology

Abstract

Most children with asthma have their disease easily controlled if low-dose inhaled corticosteroids (ICSs) are regularly and correctly administered. If a child presents with asthma which is apparently resistant to therapy with high-dose ICS and other controllers, then they have problematic severe asthma. However, in light of the UK National Review of Asthma Deaths, definitions of severe asthma based solely on the levels of prescribed treatment are too narrow. A detailed assessment of all such children should be performed. First, the diagnosis of asthma should be confirmed, then co-morbidities assessed. Next, a nurse-led assessment further characterizes the problem, conventionally categorizing the child as either having difficult asthma or severe therapy-resistant asthma. Here, we reassess in particular the interactions between, and management of, these two categories, highlighting that this dichotomous classification may need reconsideration. We use bronchoscopy and an intramuscular steroid injection to determine if the child has steroid-resistant asthma, using a novel, multidomain approach because the adult definition does not apply to around half the children we see. Finally, we highlight some mechanistic data which have emerged from this protocol such as the absence of T-helper 2 (TH2) cytokines even in eosinophilic severe asthma and the potential role of the innate epithelial cytokine IL-33, novel data on lineage negative innate lymphoid cells, which we can measure in induced sputum, and demonstrating that intraepithelial neutrophils are associated with better, not worse asthma outcomes. Severe paediatric asthma is very different from severe asthma in adults, and approaches must not be uncritically extrapolated from adult disease to children.

Integrity signals

Registry

Crossref · 10.1111/resp.13085

Cites

96 of 96 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Despite interventions and treatments aimed at addressing modifiable factors and comorbidities, some children with difficult asthma and Asthma plus may not improve because of continued poor adherence with medications or ongoing high exposure to allergens, in which case they should be considered as having refractory difficult asthma or refractory Asthma plus.

    “However, despite interventions and treatments aimed at addressing modifiable factors and comorbidities, some children with DA and Asthma plus may not improve [e.g., because of the continued poor adherence with medications (50, 68), or ongoing high exposure to allergens (69–71)], in which case they should be considered as having refractory DA or refractory Asthma plus (46, 72).”

    From Epidemiology of Asthma in Children and Adults (2019) · cites this paper as [72]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Bush, A., Fleming, L., & Saglani, S.
Affiliations
Royal Brompton & Harefield NHS Foundation Trust (GB)
Corresponding author
Bush, Andrew
Venue
Respirology
Publisher
Wiley
Published
2017-05-25
Volume
22
Issue
5
Pages
886-897
ISSN
  • 1323-7799 (ISSN-L)
  • 1440-1843
OpenAlex
W2619495389
Cited by
106
References
96
Citations by year
2026: 4 · 2025: 3 · 2024: 7 · 2023: 8 · 2022: 9 · 2021: 9 · 2020: 16 · 2019: 27 · 2018: 17 · 2017: 6
FWCI
2.21
Type
journal article
Language
en
Open access
closed
Locations
  • Respirology (publishedVersion)
  • PubMed (publishedVersion)
  • Spiral (Imperial College London) (submittedVersion)
Funders
Imperial College London
Topics
  • Health Sciences › Medicine › Physiology › Asthma and respiratory diseases
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Occupational exposure and asthma
  • Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
Keywords
therapy-resistant asthma, difficult-to-treat asthma, steroid-resistant asthma, inhaled corticosteroids, bronchoscopy, eosinophilic asthma, Th2 cytokines, IL-33, innate lymphoid cells, induced sputum, asthma comorbidity, asthma classification
MeSH terms
Interleukin-33, Nurse Specialists, Adrenal Cortex Hormones, Asthma, Bronchoscopy, Child, Drug Resistance, Humans, Immunity, Innate, Lymphocytes, Nursing Assessment, Pulmonary Eosinophilia, Severity of Illness Index, Anti-Asthmatic Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review